Amino acid replacement: G297E.
G14995979A
G297E | eag-PA; G297E | eag-PB; G280E | eag-PC; G295E | eag-PD; G278E | eag-PE; G287E | eag-PF; G280E | eag-PG
G297E
Site of nucleic acid difference inferred by FlyBase based on reported amino acid change.
gain of function
eagG297E flies do not show temperature-sensitive paralysis, the flies are well coordinated and their flight appears normal.
The amplitude and duration of the excitatory junctional potential (ejp) elicited in the muscle at the neuromuscular junction in eagG297E larvae at 0.15 mM CaCl2 is not significantly affected compared to wild type. The onset rate of long-term facilitation is also unaffected in the mutants.
eagG297E is a suppressor of abnormal neurophysiology phenotype of Sh14
eagG297E is a suppressor of increased rate of movement | dominant phenotype of Sh14
eagG297E/eag[+] is a suppressor of abnormal neurophysiology phenotype of Sh14
eagG297E/eagG297E is a suppressor of abnormal neurophysiology phenotype of Sh14
eagG297E/eag[+] is a suppressor of embryonic/larval neuromuscular junction phenotype of Sh14
eagG297E/eagG297E is a suppressor of embryonic/larval neuromuscular junction phenotype of Sh14
eagG297E suppresses the mutant excitatory junctional potential (ejp) phenotype that is seen at low Ca2+ levels (0.1mM) in Sh14 larvae in a dosage dependent manner; eagG297E/+ results in a moderate decrease in the ejp amplitude, but not ejp duration, while eagG297E/eagG297E significantly decreases both ejp amplitude and duration. This suppression requires extracellular Mg2+.
The average amplitude of the excitatory junctional current (ejc) at the neuromuscular junction is significantly smaller in eagG297E Sh14 animals than in eag+ Sh14 animals. The average amplitude of the spontaneous miniature excitatory junctional potential (mejp) is almost identical in eagG297E Sh14 and eag+ Sh14 animals.